Comparative Bactericidal Activity of Representative Β-Lactams Against Enterobacterales, Acinetobacter Baumannii and Pseudomonas Aeruginosa.

Background There is surprisingly little comparative published data on the bactericidal action of different sub-classes of beta-lactams against aerobic Gram-negative rods, and the assumption is that all behave in the same way. Objectives To describe a systematic investigation of a representative penicillin, cephalosporin, monobactam and carbapenem against Escherichia coli, Klebsiella pneumoniae, Acinetobacter baumannii and Pseudomonas aeruginosa. Methods Concentration-time-kill curves (TKC) were determined for three strains each of E. coli, K. pneumoniae, A. baumannii and P. aeruginosa. All strains were susceptible to the agents used. The antibiotics were piperacillin/tazobactam, ceftazidime, aztreonam and meropenem. The initial inoculum was 10(6) cfu/mL and TKC were determined over 48 h. The area-under-the-bacterial-kill curve to 24 h (AUBKC 24 log cfu center dot h/mL) and 48 h (AUBKC 48) were used to measure antibacterial effect (ABE). Population profiles before and after antibiotic exposure were recorded. Results Against E. coli and K. pneumoniae meropenem had a maximal ABE at >= MIC x 1 concentrations while piperacillin/tazobactam and ceftazidime had maximal effect at >= MIC x 4 and aztreonam at >= MIC x 8 concentrations. Ceftazidime, aztreonam and meropenem had less ABE against K. pneumoniae than E. coli. Against P. aeruginosa, meropenem was most bactericidal, with a maximum ABE at 8x/16 x MIC. Other beta-lactams had notably less ABE. In contrast, against A. baumannii, ceftazidime and meropenem had the greatest ABE, with a maximal effect at >= MIC x 4, concentration changes in population profiles were least apparent with E. coli. Conclusions beta-Lactam sub-classes (penicillins, cephalosporins, monobactams and carbapenems) have different antibacterial effects against E. coli, K. pneumoniae, A. baumannii and P. aeruginosa. Extrapolation of in vitro pharmacodynamic findings from one species to another or one sub-class of beta-lactam to another is not justified.